Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study

International Journal of Cancer

Volumn 120, Issue 3, 2007, Pages 638-641

  Welzel, Tania M ^a   Mellemkjaer, Lene ^b   Gloria, Gridley ^a   Sakoda, Lori C ^a   Hsing, Ann W ^a   El Ghormli, Laure ^a   Olsen, Jorgen H ^b   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Intrahepatic cholangiocarcinoma; Population based case control study; Risk factors

Indexed keywords

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHOLELITHIASIS; COMMON BILE DUCT STONE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; ENTERITIS; FEMALE; HISTOLOGY; HOSPITAL DISCHARGE; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; BILE DUCT DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CHOLANGITIS; CHOLECYSTOLITHIASIS; CHOLEDOCHOLITHIASIS; DENMARK; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS;

EID: 33845792859     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22283     Document Type: Article

References (28)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-14.
2. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002;89:962-70.
3. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Jang KT, Lee NY, Kim S, Hong ST. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol 2006;44:1066-73.
4. Kubo S, Kinoshita H, Hirohashi K, Hamba H. Hepatolithiasis associated with cholangiocarcinoma. World J Surg 1995;19:637-41.
5. Welzel TM, McGlynn KA, Hsing A, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873-5.
6. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25.
7. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzcn H, Wallerstedt S, Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-15.
8. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
9. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998;27:311-16.
10. Macfaul GR, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol 2006;22:288-93.
11. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic Cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005;128:620-6.
12. Storm HH, Michelsen EV. Clemmensen IH, Pihl J. The Danish cancer registry-history, content, quality and use. Dan Med Bull 1997;44:535-9.
13. Storm HH, Manders T, Friis S, Band S. Cancer incidence in Denmark. Copenhagen. Denmark: Danish Cancer Society, 1989.
14. World Health Organization. International classification of diseases for oncology (ICD-O). Geneva. Switzerland: WHO. 1976.
15. Danish National Board of Health. The activity in the hospital care system 1979. Copenhagen, Denmark: Danish National Board of Health, 1981. (In Danish).
16. Danish National Board of Health. Classification of diseases. Copenhagen: Danish National Board of Health, 1976. (In Danish).
17. Danish National Board of Health. Classification of surgical procedures and therapies. Copenhagen. Denmark: Danish National Board of Health, 1973. (In Danish).
18. Lazaridis KN, Gores GJ. Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis 2006;26:42-51.
19. Alison MR, Lovell MJ. Liver cancer: the role of stem cells. Cell Prolif 2005;38:407-21.
20. Arteel G, Marsanto L, Mendez C, Bentley F, McClain CJ. Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 2003;17:625-47.
21. Dey A, Cederbaum Al. Alcohol and oxidative liver injury. Hepatology 2006;43 (Suppl 1):S63-S74.
22. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-67.
23. Kubo S, Uenishi T, Yamamoto S, Hai S, Yamamoto T, Ogawa M, Takemura S, Shuto T, Tanaka H, Yamazaki O, Hirohashi K, Kinoshita H. Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 2004;29:223-7.
24. Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, Adami HO. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 1993;20:342:1262-5.
25. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
26. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF, Jr. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
27. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF, Jr. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-7.
28. Bulujic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, Lohr M. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 20021;95:1946-53.